We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-0.98%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$876M
AUM Growth
-$55.2M
(-5.9%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
15.65%
Holding
1,097
New
348
Increased
154
Reduced
158
Closed
436
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$13.9M |
| 2 |
CVS Health
CVS
|
+$12.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$11.6M |
| 4 |
Skyworks Solutions
SWKS
|
+$10.5M |
| 5 |
Nike
NKE
|
+$9.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$27.9M |
| 2 |
Starbucks
SBUX
|
+$11.8M |
| 3 |
Goldman Sachs
GS
|
+$10.9M |
| 4 |
Coca-Cola
KO
|
+$8.98M |
| 5 |
T-Mobile US
TMUS
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.88% |
| 3 | Consumer Discretionary | 12.26% |
| 4 | Financials | 8.85% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTTR
651
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $21.9K | ﹤0.01% |
+10,100
| New | +$28.3K |
|
652
Rockwell Medical
RMTI
$27.6M
| $21.8K | ﹤0.01% |
+1,050
| New | +$31.9K |
|
653
Ocugen
OCGN
$427M
| $19.1K | ﹤0.01% |
+47,700
| New | +$23.5K |
|
|
CGC
654
Canopy Growth
CGC
$390M
| $17.8K | ﹤0.01% |
2,270
-12,420
| -85% | -$76K |
|
|
ESPR
655
DELISTED
Esperion Therapeutics
ESPR
| $17.2K | ﹤0.01% |
+17,600
| New | +$25.5K |
|
656
Rigel Pharmaceuticals
RIGL
$692M
| $16.3K | ﹤0.01% |
1,508
-1,280
| -46% | -$15.4K |
|
|
LLAP
657
DELISTED
Terran Orbital Corporation
LLAP
| $9.66K | ﹤0.01% |
11,600
-39,400
| -77% | -$52.2K |
|
658
Senseonics Holdings Inc
SENS
$262M
| $9.42K | ﹤0.01% |
+780
| New | +$10.8K |
|
|
HOOK
659
DELISTED
HOOKIPA Pharma
HOOK
| $8.91K | ﹤0.01% |
1,446
-130
| -8% | -$955 |
|
|
ADAP
660
DELISTED
Adaptimmune Therapeutics
ADAP
| $8.18K | ﹤0.01% |
10,486
-1,100
| -9% | -$923 |
|
|
RAD
661
DELISTED
Rite Aid Corporation
RAD
| $6.32K | ﹤0.01% |
+14,100
| New | +$18.9K |
|
662
American Airlines Group
AAL
$9.9B
| – | – |
-34,300
| Closed | -$615K |
|
663
Aaon
AAON
$8.27B
| – | – |
-4,500
| Closed | -$284K |
|
664
AbCellera Biologics
ABCL
$1.6B
| – | – |
-36,090
| Closed | -$233K |
|
665
Arbor Realty Trust
ABR
$977M
| – | – |
-15,400
| Closed | -$228K |
|
666
Acadia Pharmaceuticals
ACAD
$4.35B
| – | – |
-11,837
| Closed | -$283K |
|
667
Acadia Healthcare
ACHC
$2.99B
| – | – |
-9,100
| Closed | -$725K |
|
668
Archer Daniels Midland
ADM
$40.1B
| – | – |
-3,880
| Closed | -$293K |
|
669
American Electric Power
AEP
$72.7B
| – | – |
-12,000
| Closed | -$1.01M |
|
670
AerCap
AER
$23.9B
| – | – |
-33,764
| Closed | -$2.14M |
|
671
AES
AES
$10.6B
| – | – |
-67,300
| Closed | -$1.4M |
|
672
First Majestic Silver
AG
$8.01B
| – | – |
-10,600
| Closed | -$59.9K |
|
673
AGCO
AGCO
$8.71B
| – | – |
-6,200
| Closed | -$815K |
|
674
Assurant
AIZ
$13.7B
| – | – |
-4,119
| Closed | -$518K |
|
675
Arthur J. Gallagher & Co
AJG
$65.1B
| – | – |
-10,766
| Closed | -$2.36M |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Bayesian Capital Management held 1,097 positions worth $876M, down 5.9% from $931M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bayesian Capital Management's Q3 2023 filing shows 348 new, 154 increased, 158 reduced and 436 closed positions. Its largest new stake was Walt Disney: 162,687 shares worth $13.2M. The largest sale was NVIDIA, an estimated $27.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2023 buy was Walt Disney: 162,687 shares worth $13.2M.
- Bayesian Capital Management added most to CVS Health in Q3 2023, an estimated $12.2M increase.
- Bayesian Capital Management's biggest Q3 2023 reduction was Coca-Cola, cutting an estimated $8.98M.
- Bayesian Capital Management fully exited NVIDIA in Q3 2023, selling an estimated $27.9M.
- Bayesian Capital Management's ten largest holdings make up 16% of its $876M portfolio in Q3 2023.
- Bayesian Capital Management opened 348 new positions and closed 436 in Q3 2023.
- Bayesian Capital Management's portfolio value fell 5.9% quarter-over-quarter to $876M.
Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.